• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善晚期呼吸系统疾病和严重呼吸困难患者的生活质量。

Improving the quality of life of people with advanced respiratory disease and severe breathlessness.

作者信息

Booth Sara, Johnson Miriam J

机构信息

Cambridge Breathlessness Intervention Service, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.

Cicely Saunders Institute, King's College London, London, UK.

出版信息

Breathe (Sheff). 2019 Sep;15(3):198-215. doi: 10.1183/20734735.0200-2019.

DOI:10.1183/20734735.0200-2019
PMID:31508158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6717608/
Abstract

UNLABELLED

Advanced respiratory disease imposes a greater symptom burden than many cancers but not does have comparable recognition of the need for supportive and palliative care or the infrastructure for its systematic delivery. Consequently, many people with advanced respiratory disease (and those closest to them) have a poor quality of life, disabled by chronic breathlessness, fatigue and other symptoms. They are socially isolated by the consequences of long-term illness and are often financially impoverished. The past decade has seen an increasing realisation that care for this group must improve and that symptom management must be prioritised. Clinical guidelines recommend person-centred care, including access to supportive and palliative care as needed, as part of standard medical practice. Advanced lung disease clinics and specialist breathlessness services (pioneered within palliative care) are developing within respiratory medicine services but are provided inconsistently. This review covers the comprehensive assessment of the patient with advanced respiratory disease, the importance of supporting carers and the current best practice in the management of breathlessness, fatigue and cough. It also suggests ways to incorporate person-centred care into the general respiratory clinic, assisted by better liaison with specialist palliative and primary care. Emerging evidence shows that excellent symptom management leads to better clinical outcomes and reduces inappropriate use of emergency medical services.

KEY POINTS

People living with advanced respiratory disease and severe chronic breathlessness (and those closest to them) have a poor quality of life.Chronic breathlessness is a disabling symptom, and acute-on-chronic/episodic breathlessness is frightening to experience and observe.Chronic breathlessness imposes profound physical limitations and psychosocial burdens on those suffering from it or living with someone experiencing it.Fatigue and cough are two other cardinal symptoms of advanced respiratory disease, with very detrimental effects on quality of life.The impact of all these symptoms can be alleviated to a variable extent by a predominantly non-drug complex intervention.Many of the interventions are delivered primarily by allied health or nursing professionals.Doctors, nurses and other health professionals also need to play an active part in promoting quality of life as part of excellent medical care.A person-centred, psychologically informed approach is needed by all clinicians treating patients with advanced respiratory disease.

EDUCATIONAL AIMS

To give specialist respiratory clinicians practical clinical tools to help improve the quality of life of their patients with advanced respiratory disease and chronic breathlessness.To outline the evidence base for these interventions with reference to definitive sources.To highlight the importance of person-centred care in people with respiratory disease at all stages of illness.

摘要

未标注

晚期呼吸系统疾病所带来的症状负担比许多癌症更重,但在对支持性和姑息治疗的需求认识方面,以及在系统性提供此类治疗的基础设施方面,却没有得到同等程度的重视。因此,许多晚期呼吸系统疾病患者(以及与他们关系最密切的人)生活质量很差,因慢性呼吸困难、疲劳及其他症状而丧失能力。他们因长期患病而在社会上孤立无援,且常常陷入经济困境。在过去十年中,人们越来越意识到必须改善对这一群体的护理,并且必须优先进行症状管理。临床指南建议将以人为本的护理,包括根据需要提供支持性和姑息治疗,作为标准医疗实践的一部分。晚期肺病诊所和专门的呼吸困难服务(最初在姑息治疗中开展)正在呼吸医学服务中发展,但提供情况并不一致。本综述涵盖对晚期呼吸系统疾病患者的全面评估、支持护理人员的重要性,以及目前在呼吸困难、疲劳和咳嗽管理方面的最佳实践。它还提出了一些方法,通过与专科姑息治疗和初级护理更好地联络,将以人为本的护理纳入普通呼吸诊所。新出现的证据表明,出色的症状管理可带来更好的临床结果,并减少对紧急医疗服务的不当使用。

关键点

晚期呼吸系统疾病患者和严重慢性呼吸困难患者(以及与他们关系最密切的人)生活质量很差。慢性呼吸困难是一种致残症状,而慢性基础上的急性/发作性呼吸困难对经历者和观察者来说都令人恐惧。慢性呼吸困难给患者本人或与患者共同生活的人带来了严重的身体限制和心理社会负担。疲劳和咳嗽是晚期呼吸系统疾病的另外两个主要症状,对生活质量有非常不利的影响。通过主要是非药物的综合干预,所有这些症状的影响在不同程度上都可以得到缓解。许多干预措施主要由专职医疗人员或护理专业人员提供。医生、护士和其他卫生专业人员也需要积极参与,将提高生活质量作为优质医疗护理的一部分。所有治疗晚期呼吸系统疾病患者的临床医生都需要采用以人为本、注重心理的方法。

教育目标

为专科呼吸临床医生提供实用的临床工具,以帮助改善晚期呼吸系统疾病和慢性呼吸困难患者的生活质量。参考权威资料概述这些干预措施的证据基础。强调在疾病各个阶段对呼吸系统疾病患者进行以人为本护理的重要性。

相似文献

1
Improving the quality of life of people with advanced respiratory disease and severe breathlessness.改善晚期呼吸系统疾病和严重呼吸困难患者的生活质量。
Breathe (Sheff). 2019 Sep;15(3):198-215. doi: 10.1183/20734735.0200-2019.
2
Provision of palliative care for people with chronic obstructive pulmonary disease: a narrative review.为慢性阻塞性肺疾病患者提供姑息治疗:叙事性综述。
Ann Palliat Med. 2024 Jul;13(4):1012-1027. doi: 10.21037/apm-24-11. Epub 2024 Jun 17.
3
4
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
5
The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.针对患有晚期疾病的成年人及其护理人员的医院专科姑息治疗的有效性和成本效益。
Cochrane Database Syst Rev. 2020 Sep 30;9(9):CD012780. doi: 10.1002/14651858.CD012780.pub2.
6
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
7
Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.新门诊呼吸困难支持服务的开发、效果和成本效益:一项 III 期快速通道随机对照试验的研究方案。
BMC Pulm Med. 2012 Sep 19;12:58. doi: 10.1186/1471-2466-12-58.
8
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.
9
Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers.癌症与慢性阻塞性肺疾病中的呼吸困难:运用定性研究方法描述患者及护理人员的体验
Palliat Support Care. 2003 Dec;1(4):337-44. doi: 10.1017/s1478951503030499.
10
Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers.早期姑息治疗干预对改善原发性脑恶性肿瘤患者及其照护者结局的影响。
Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013440. doi: 10.1002/14651858.CD013440.pub2.

引用本文的文献

1
Social determinants of health on all-cause and cause-specific mortality in US adults with chronic obstructive pulmonary disease: NHANES 2005-2018.美国慢性阻塞性肺疾病成年人全因死亡率和特定病因死亡率的健康社会决定因素:2005 - 2018年美国国家健康与营养检查调查
PLoS One. 2025 May 15;20(5):e0322654. doi: 10.1371/journal.pone.0322654. eCollection 2025.
2
Psychometric Properties of the Turkish Version of the Breathlessness Catastrophizing Scale in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者中土耳其语版呼吸急促灾难化量表的心理测量特性
Thorac Res Pract. 2025 Jan 3;26(1):17-24. doi: 10.4274/ThoracResPract.2024.24035.
3

本文引用的文献

1
No Shortcuts to Safer Opioid Prescribing.安全开具阿片类药物处方没有捷径可走。
N Engl J Med. 2019 Jun 13;380(24):2285-2287. doi: 10.1056/NEJMp1904190. Epub 2019 Apr 24.
2
Airflow relieves chronic breathlessness in people with advanced disease: An exploratory systematic review and meta-analyses.气流缓解晚期疾病患者的慢性呼吸困难:探索性系统评价和荟萃分析。
Palliat Med. 2019 Jun;33(6):618-633. doi: 10.1177/0269216319835393. Epub 2019 Mar 8.
3
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
Editorial: Model organisms in respiratory pharmacology 2023.
社论:2023年呼吸药理学中的模式生物
Front Pharmacol. 2025 Jan 13;15:1540222. doi: 10.3389/fphar.2024.1540222. eCollection 2024.
4
Exploring the association between socioeconomic inequalities in chronic respiratory disease and all-cause mortality in China: findings from the China Health and Retirement Longitudinal Study.探索中国慢性呼吸道疾病的社会经济不平等与全因死亡率之间的关联:来自中国健康与养老追踪调查的发现
Front Public Health. 2025 Jan 7;12:1472074. doi: 10.3389/fpubh.2024.1472074. eCollection 2024.
5
The Experiences and Perceptions of Telehealth in Patients Living With Advanced Chronic Obstructive Pulmonary Disease: A Qualitative Evidence Synthesis.晚期慢性阻塞性肺疾病患者对远程医疗的体验与认知:一项定性证据综合分析
J Adv Nurs. 2025 Apr;81(4):1700-1716. doi: 10.1111/jan.16493. Epub 2024 Oct 18.
6
Explain Breathlessness: Could 'Usual' Explanations Contribute to Maladaptive Beliefs of People Living with Breathlessness?解释呼吸急促:“常见”的解释会导致呼吸急促患者产生适应不良的信念吗?
Healthcare (Basel). 2024 Sep 10;12(18):1813. doi: 10.3390/healthcare12181813.
7
The effect of unpredictability on the perception of breathlessness: a narrative review.不可预测性对呼吸困难感知的影响:一项叙述性综述。
Front Rehabil Sci. 2024 Jan 9;4:1339072. doi: 10.3389/fresc.2023.1339072. eCollection 2023.
8
Navigating Compassion: A Comprehensive Review of Palliative Care in Respiratory Medicine.《驾驭同情心:呼吸医学中的姑息治疗综合综述》
Cureus. 2023 Dec 16;15(12):e50613. doi: 10.7759/cureus.50613. eCollection 2023 Dec.
9
Pulmonary Rehabilitation with and without a Cognitive Behavioral Intervention for Breathlessness in People Living with Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial.慢性阻塞性肺疾病患者呼吸急促的有或无认知行为干预的肺康复:随机对照试验
J Clin Med. 2023 Nov 24;12(23):7286. doi: 10.3390/jcm12237286.
10
Prevalence and Knowledge of Respiratory Symptoms Among the General Public in the Southern Area of Najran, Saudi Arabia: A Cross-Sectional Health Survey Study.沙特阿拉伯奈季兰南部地区普通民众呼吸道症状的患病率及认知情况:一项横断面健康调查研究
Int J Gen Med. 2023 Sep 7;16:4077-4090. doi: 10.2147/IJGM.S418152. eCollection 2023.
广泛性焦虑障碍的药物治疗:系统评价和网络荟萃分析。
Lancet. 2019 Feb 23;393(10173):768-777. doi: 10.1016/S0140-6736(18)31793-8. Epub 2019 Jan 31.
4
Acute-on-Chronic Breathlessness: Recognition and Response.急性加重期慢性呼吸困难:识别与应对
J Pain Symptom Manage. 2019 May;57(5):e4-e5. doi: 10.1016/j.jpainsymman.2019.01.012. Epub 2019 Jan 31.
5
Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis.为晚期疾病和慢性呼吸困难患者提供的整体服务:一项系统评价和荟萃分析。
Thorax. 2019 Mar;74(3):270-281. doi: 10.1136/thoraxjnl-2018-211589. Epub 2018 Nov 29.
6
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.舍曲林治疗症状性慢性呼吸困难的双盲随机试验。
Eur Respir J. 2019 Jan 17;53(1). doi: 10.1183/13993003.01270-2018. Print 2019 Jan.
7
Symptom perception, placebo effects, and the Bayesian brain.症状感知、安慰剂效应与贝叶斯大脑
Pain. 2019 Jan;160(1):1-4. doi: 10.1097/j.pain.0000000000001367.
8
Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.肺动脉高压慢性呼吸困难的缓释吗啡:一项随机、双盲、安慰剂对照、交叉研究。
J Pain Symptom Manage. 2018 Oct;56(4):483-492. doi: 10.1016/j.jpainsymman.2018.07.010. Epub 2018 Jul 19.
9
Integrated respiratory and palliative care may improve outcomes in advanced lung disease.综合呼吸与姑息治疗可能改善晚期肺病的治疗效果。
ERJ Open Res. 2018 Feb 16;4(1). doi: 10.1183/23120541.00102-2017. eCollection 2018 Jan.
10
Living with breathlessness: a systematic literature review and qualitative synthesis.呼吸困难的生活:系统文献回顾和定性综合。
Eur Respir J. 2018 Feb 21;51(2). doi: 10.1183/13993003.01477-2017. Print 2018 Feb.